Article thumbnail

Eprosartan mesylate, an angiotensin II receptor antagonist

By Jing-Jing Qian, Xiu-Rong Hu, Jianming Gu and Su-Xiang Wu

Abstract

The title compound, eprosartan mesylate {systematic name: 2-butyl-1-(4-carb­oxy­benz­yl)-5-[(E)-2-carb­oxy-3-(thio­phen-2-yl)prop-1-en­yl]-1H-imidazol-3-ium methane­sulfonate}, C23H25N2O4S+·CH3O3S−, one of the angiotensin II-receptor antagonists, is effective in regulating hypertension, induced or exacerbated by angiotensin II, and in the treatment of congestive heart failure, renal failure and glaucoma. In the eprosartan residue, which appears in this crystal in the cationic imidazolium form, the benzene ring plane is almost orthogonal to that of the imidazole ring, making a dihedral angle of 87.89 (2)°. The thio­phene ring forms dihedral angles of 66.54 (2) and 67.12 (2)° with the benzene and imidazole rings, respectively. The imidazolium NH group and the H atom of the aromatic carboxyl group participate in hydrogen bonds with the the O atoms of the anion, thus forming centrosymmetric aggregates made up of two cations and two anions each. The second carboxyl group further links the above-mentioned aggregates through a conventional centrosymmetric hydrogen-bonding motif into infinite chains along [011]

Topics: Organic Papers
Publisher: International Union of Crystallography
OAI identifier: oai:pubmedcentral.nih.gov:3099799
Provided by: PubMed Central

To submit an update or takedown request for this paper, please submit an Update/Correction/Removal Request.

Suggested articles

Citations

  1. Crystal packing of the title compound viewed approximately down the a axis. H-bonds are shown as dashed lines. 2-butyl-1-(4-carboxybenzyl)-5-[(E)-2-carboxy-3-(thiophen-2-yl)prop- 1-enyl]-1H-imidazol-3-ium methanesulfonate Crystal data
  2. (2007). CrystalStructure. Rigaku Corpporation,
  3. Fractional atomic coordinates and isotropic or equivalent isotropic displacement parameters (Å2) x y z Uiso*/Ueq
  4. (2011). organic compounds Acta Cryst.
  5. (2009). The asymmetric unit, comprising eprosartan cation and mesylate anion, is shown in Fig.1. Geometric parameters of the cation are comparable to that of the neutral eprosartan (Wu et al.,
  6. (2004). The Eprosartan Investigation Group